Multi-omics studies demonstrate that Gamabufotalin exerts anti-HCC effects through STAMBPL1-mediated regulation of amino acid metabolism (Zheng, et al., 2024). This evidence concerns the gene STAMBPL1 and hepatocellular carcinoma.